Lataa...
A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52: A protocol for mixed treatment comparisons meta-analysis
BACKGROUND: According to the centers for disease control and prevention, 14% of American adults have diabetes – 10% know it, and more than 4% go undiagnosed. Sotagliflozin is a new type of diabetes drug This study is to compare the efficacy of Sotagliflozin therapy for Diabetes Mellitus (DM) between...
Tallennettuna:
| Julkaisussa: | Medicine (Baltimore) |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer Health
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6882651/ https://ncbi.nlm.nih.gov/pubmed/31764805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017976 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|